Bixin and fucoxanthin sensitize human lung cancer and cervical cancer cell to cisplatin in vitro
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bixin and fucoxanthin sensitize human lung cancer and cervical cancer cell to cisplatin in vitro ; volume:14 ; number:1 ; day:18 ; month:12 ; year:2021 ; pages:1-8 ; date:12.2021
BMC Research Notes / Biomed Central; 14, Heft 1 (18.12.2021), 1-8, 12.2021
- Creator
-
Nurcahyanti, Agustina Dwi Retno
Kusmita, Lia
Wink, Michael
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-021-05866-4
- URN
-
urn:nbn:de:101:1-2022041319473325101842
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nurcahyanti, Agustina Dwi Retno
- Kusmita, Lia
- Wink, Michael
- SpringerLink (Online service)
Other Objects (12)
Radiosensitizers in cervical cancer. Cisplatin and beyond
MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells
Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
Combined time-restricted feeding and cisplatin enhance the anti-tumor effects in cisplatin-resistant and -sensitive lung cancer cells
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Human Papillomaviruses and Cervical Cancer
Cervical cancer
Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer
Radiosensitizers in cervical cancer. Cisplatin and beyond
MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells
Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
Combined time-restricted feeding and cisplatin enhance the anti-tumor effects in cisplatin-resistant and -sensitive lung cancer cells
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Human Papillomaviruses and Cervical Cancer
Cervical cancer
Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer
Radiosensitizers in cervical cancer. Cisplatin and beyond
MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells
Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
Combined time-restricted feeding and cisplatin enhance the anti-tumor effects in cisplatin-resistant and -sensitive lung cancer cells
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Human Papillomaviruses and Cervical Cancer
Cervical cancer
Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer